Skip to main content

Table 3 The subsequent antitumor therapies prescribed to the enrolled hepatocellular carcinoma patients after diagnosis of tumor recurrence

From: Adjuvant transcatheter arterial chemoembolization after curative resection for hepatocellular carcinoma patients with solitary tumor and microvascular invasion: a randomized clinical trial of efficacy and safety

Antitumor therapy

Hepatectomy-TACE group (n = 56)

Hepatectomy Alone group (n = 46)

P-value

Locoregional ablation

27

8

< 0.001

Hepatectomya

2

2

1.000

Systemic chemotherapy

1

5

0.210

Sorafenib

14

5

0.029

TACE

12

26

0.016

  1. Hepatectomy-TACE: radical hepatectomy followed by adjuvant transcatheter arterial chemoembolization; Hepatectomy Alone: had undergone only radical hepatectomy
  2. a Resection of the recurrent lesion(s) in the liver
Back to article page

Cancer Communications

ISSN: 2523-3548

Contact us